{"id":"NCT01153685","sponsor":"GlaxoSmithKline","briefTitle":"Immunogenicity & Safety Study of Fluviral速 (2010 - 2011 Season) in Adults Aged 18 to 60 Years and Over 60 Years","officialTitle":"Immunogenicity and Safety Study of GSK Biologicals' (GSK1536489A) Trivalent Split Virion Influenza Vaccine Fluviral速 (2010 - 2011 Season) in Adults Aged 18 to 60 Years and Over 60 Years.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-07-09","primaryCompletion":"2010-07-31","completion":"2010-07-31","firstPosted":"2010-06-30","resultsPosted":"2011-11-17","lastUpdate":"2018-06-08"},"enrollment":120,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Fluviral速","otherNames":[]}],"arms":[{"label":"Fluviral A Group","type":"EXPERIMENTAL"},{"label":"Fluviral B Group","type":"EXPERIMENTAL"}],"summary":"This study is designed to test the safety and immunogenicity of Fluviral速 (2010 - 2011 Season) in adults aged 18 to 60 years and over 60 years.","primaryOutcome":{"measure":"Geometric Mean Titers (GMTs) of Haemagglutination Inhibition (HI) Antibodies Against Fluviral Vaccine Strains.","timeFrame":"At Day 0 before vaccination","effectByArm":[{"arm":"Fluviral A Group","deltaMin":39.2,"sd":null},{"arm":"Fluviral B Group","deltaMin":15.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":7,"exclusionCount":23},"locations":{"siteCount":1,"countries":["Canada"]},"refs":{"pmids":["24606983"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":50},"commonTop":["Pain","Muscle aches","Fatigue","Headache","Sore throat"]}}